# Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma

> **NCT03896815** · — · NO_LONGER_AVAILABLE · sponsor: **Incyte Corporation**

## Conditions studied

_None listed._

## Interventions

- **DRUG:** INCB054329

## Key facts

- **NCT ID:** NCT03896815
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2019-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03896815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03896815, "Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03896815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*